G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 127 filers reported holding G1 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $248,168 | -55.8% | 92,600 | -10.5% | 0.00% | – |
Q4 2022 | $562,005 | +5.0% | 103,500 | +47.0% | 0.00% | – |
Q1 2022 | $535,000 | -18.8% | 70,400 | +9.1% | 0.00% | – |
Q4 2021 | $659,000 | -23.9% | 64,500 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $866,000 | -38.8% | 64,500 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $1,415,000 | -8.8% | 64,500 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $1,552,000 | +33.8% | 64,500 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $1,160,000 | +59.1% | 64,500 | +2.2% | 0.00% | 0.0% |
Q3 2020 | $729,000 | -52.4% | 63,100 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $1,531,000 | +172.4% | 63,100 | +23.7% | 0.00% | 0.0% |
Q1 2020 | $562,000 | -57.6% | 51,000 | +1.6% | 0.00% | 0.0% |
Q4 2019 | $1,327,000 | +18.7% | 50,200 | +2.2% | 0.00% | 0.0% |
Q3 2019 | $1,118,000 | -24.7% | 49,100 | +1.4% | 0.00% | -50.0% |
Q2 2019 | $1,484,000 | +102.7% | 48,400 | +9.8% | 0.00% | +100.0% |
Q1 2019 | $732,000 | -0.4% | 44,100 | +14.8% | 0.00% | 0.0% |
Q4 2018 | $735,000 | -62.1% | 38,400 | +3.5% | 0.00% | -50.0% |
Q3 2018 | $1,940,000 | +25.7% | 37,100 | +4.5% | 0.00% | 0.0% |
Q2 2018 | $1,543,000 | +17.3% | 35,500 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $1,315,000 | +359.8% | 35,500 | +146.5% | 0.00% | – |
Q4 2017 | $286,000 | – | 14,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |